X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2022/05/17/2445239/0/en/Sorrento-s-License-Partner-Lee-s-Pharm-Announces-Full-Enrollment-of-498-Patients-in-a-Phase-III-Trial-of-Socazolimab-Anti-PD-L1-Antibody-for-First-Line-Treatment-of-Extensive-Stage.html
https://www.indiatoday.in/coronavirus-outbreak/story/csir-iict-lee-pharma-to-produce-2-dg-drugs-1812889-2021-06-09
https://www.indiatoday.in/coronavirus-outbreak/story/csir-iict-lee-pharma-to-produce-2-dg-drugs-1812889-2021-06-09
https://www.globenewswire.com/news-release/2021/03/08/2188301/0/en/Lee-s-Pharmaceutical-Announces-its-Anti-PD-L1-Antibody-Socazolimab-Licensed-From-Sorrento-Therapeutics-Receives-Clearance-to-Start-Phase-3-Trial-as-a-First-line-Treatment-of-Extens.html
https://www.biospectrumasia.com/news/28/13118/regenerx-lees-pharm-to-accelerate-rgn-259-development-in-china.html
https://www.prnewswire.com/news-releases/regenerx-and-lees-pharm-to-accelerate-rgn-259-development-in-china-300818557.html
https://www.biospectrumasia.com/news/25/10336/koreas-gc-pharm-inks-a-deal-with-lees-pharmaceutical-.html
http://www.prnewswire.com/news-releases/sillajen-enrolls-first-us-patient-in-multinational-phase-3-trial-for-pexa-vec-in-advanced-liver-cancer-300242465.html
Market Place
Share 
